News
We enter into a collaboration and license agreement with Prilenia for the commercialization and co-development of Pridopidine
News
Ferrer advances research into Progressive Supranuclear Palsy (PSP) with the inclusion of the first participant in a Phase II clinical trial
Collective Action
We explore new forms of collaboration to address our society's most critical challenges
Our activities
This allows us to commit to initiatives that make a positive impact in society
Would you like to ask us a question? Contact us.
For queries, to request medical information, become a partner, request an interview, report an adverse reaction or lodge a quality complaint, please leave us a message.
Link